| Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor M Faheem, MT Rehman, M Danishuddin, AU Khan PLoS One 8 (2), e56926, 2013 | 68 | 2013 |
| M. tuberculosis ferritin (Rv3841): Potential involvement in Amikacin (AK) & Kanamycin (KM) resistance D Sharma, M Lata, M Faheem, AU Khan, B Joshi, K Venkatesan, S Shukla, ... Biochemical and biophysical research communications 478 (2), 908-912, 2016 | 34 | 2016 |
| Dominant negative mutations affect oligomerization of human pyruvate kinase M2 isozyme and promote cellular growth and polyploidy V Gupta, P Kalaiarasan, M Faheem, N Singh, MA Iqbal, RNK Bamezai Journal of biological chemistry 285 (22), 16864-16873, 2010 | 32 | 2010 |
| Virtual screening and experimental testing of B1 metallo-β-lactamase inhibitors JS Kang, AL Zhang, M Faheem, CJ Zhang, N Ai, JD Buynak, WJ Welsh, ... Journal of chemical information and modeling 58 (9), 1902-1914, 2018 | 29 | 2018 |
| Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria M Danishuddin, A Khan, M Faheem, P Kalaiarasan, M Hassan Baig, ... Journal of Biomolecular Structure and Dynamics 32 (5), 741-750, 2014 | 29 | 2014 |
| Proteomic analysis of a carbapenem-resistant Klebsiella pneumoniae strain in response to meropenem stress A Khan, D Sharma, M Faheem, D Bisht, AU Khan Journal of global antimicrobial resistance 8, 172-178, 2017 | 26 | 2017 |
| Cloning, expression and correlation of Rv0148 to amikacin & kanamycin resistance D Sharma, M Lata, M Faheem, A Ullah Khan, B Joshi, K Venkatesan, ... Current Proteomics 12 (2), 96-100, 2015 | 19 | 2015 |
| An insight into the biophysical characterization of different states of cefotaxime hydrolyzing β-lactamase 15 (CTX-M-15) MT Rehman, M Faheem, AU Khan Journal of Biomolecular Structure and Dynamics 33 (3), 625-638, 2015 | 19 | 2015 |
| Evaluation of Inhibitory Action of Novel Non β-Lactam Inhibitor against Klebsiella pneumoniae Carbapenemase (KPC-2) A Khan, M Faheem, M Danishuddin, AU Khan PLoS One 9 (9), e108246, 2014 | 19 | 2014 |
| Insignificant β‐lactamase activity of human serum albumin: no panic to nonmicrobial‐based drug resistance MT Rehman, M Faheem, AU Khan Letters in applied microbiology 57 (4), 325-329, 2013 | 16 | 2013 |
| Polycomb repressive complex 2 inhibitors: emerging epigenetic modulators N Subbarao, M Faheem, SN Khan Drug discovery today 24 (1), 179-188, 2019 | 14 | 2019 |
| Role of M. tuberculosis protein Rv2005c in the aminoglycosides resistance D Sharma, M Lata, M Faheem, AU Khan, B Joshi, K Venkatesan, S Shukla, ... Microbial pathogenesis 132, 150-155, 2019 | 8 | 2019 |
| Mutation S115T in IMP-type metallo-β-lactamases compensates for decreased expression levels caused by mutation S119G CJ Zhang, M Faheem, P Dang, MN Morris, P Kumar, P Oelschlaeger Biomolecules 9 (11), 724, 2019 | 5 | 2019 |
| Role of synonymous mutations in the evolution of TEM β-lactamase genes M Faheem, CJ Zhang, MN Morris, J Pleiss, P Oelschlaeger Antimicrobial Agents and Chemotherapy 65 (6), 10.1128/aac. 00018-21, 2021 | 3 | 2021 |
